Skip to main content

Day: November 6, 2019

Danone: Information on the total number of voting rights and shares

DANONEFrench Société anonyme with a capital of €171 530 201,50.Registered Office: 17, boulevard Haussmann, 75009 Paris.Registered with the Paris Commerce and Company Registry under number 552 032 534Information on the total number of voting rights and sharesin compliance with Article L. 233-8 II of the French Commercial Code and with Article 223-16 of the General Regulation of the Financial Markets Authority (AMF- Autorité des Marchés Financiers) (1) The total number of theoretical voting rights (or “gross” voting rights) is used as the basis for calculating the crossing of shareholding thresholds. In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended.(2) The total number of exercisable...

Continue reading

DANONE : Informations relatives au nombre total de droits de vote et d’actions

DANONESociété anonyme à Conseil d’Administration au capital de 171 530 201,50€.Siège social : 17, boulevard Haussmann, 75009 Paris.552 032 534 R.C.S. Paris.Informations relatives au nombre total de droits de vote et d’actionsprévues par l’article L. 233-8 II du code de commerce et l’article 223-16 du règlement général de l’Autorité des marchés financiers(1) Le nombre de droits de vote théoriques (ou droits de vote « bruts »), sert de base de calcul pour les franchissements de seuils. Conformément à l’article 223-11 du Règlement Général de l’AMF, ce nombre est calculé sur la base de l’ensemble des actions auxquelles sont attachés des droits de vote, y compris les actions privées de droit de vote.(2) Le nombre de droits de vote exerçables (ou droits de vote « nets») est calculé en ne tenant pas compte des actions privées de droit de vote....

Continue reading

Droits de vote & actions – Octobre 2019

HOPSCOTCH GROUPEInformation mensuelle relative au nombre total des droits de vote et d’actions composant le capital socialArticle 223-16 du règlement Général de l’Autorité des Marchés Financiers*Total réel = nombre total de droits de vote attachés au nombre total d’actions – actions privées de droit de vote (auto détention,…).Pièce jointedroitsdevote 31 oct 2019

Continue reading

United Health Products Reschedules Corporate Update Call

HENDERSON, Nev., Nov. 06, 2019 (GLOBE NEWSWIRE) — United Health Products, Inc. (OTC: UEEC) is rescheduling its corporate update conference call conference to Thursday November 7, 2019 at 4:30 pm Eastern Time; the call was originally scheduled for 11 am Eastern Time on the same date. Douglas Beplate CEO and Louis Schiliro COO will give the update. There will be no Q&A. To listen to the discussion:Participant InstructionsCall your Dial-In Number: (712) 451-0011Enter your Access Code: 291859About United Health Products Inc.United Health Products develops technology; manufactures and markets patented hemostatic products for the healthcare and wound care sectors. The product, HemoStyp, is derived from oxidized regenerated cellulose. HemoStyp is an all-natural product designed to control bleeding. UHP is focused on identifying new...

Continue reading

Approximately 67.4 per cent of Nexstim Plc’s Offer Warrants under Warrant Plan 2019 used for subscription of shares

Company announcement, Inside information, Helsinki, 6 November at 7.15 pm (EET)Approximately 67.4 per cent of Nexstim Plc’s Offer Warrants under Warrant Plan 2019 used for subscription of sharesThe share subscription period based on Nexstim Plc’s (NXTMH:HEX, NXTMS:STO) (“Nexstim” or the “Company”) Offer Warrants 2019 ended on 4 November 2019. Based on the Offer Warrants, 10,511,689 new shares were subscribed for and the Company will receive approximately EUR 1.2 million in proceeds before transaction fees and expenses.As announced on 21 October 2019, the Offer Warrants were secured to 100 per cent through subscription commitments and underwriting commitments, and additional directed issues were decided on. Subject to the approval of the Extraordinary General Meeting of Shareholders to be held on 11 November 2019,...

Continue reading

Noin 67,4 prosenttia Nexstim Oyj:n Antioikeuksista 2019 on käytetty osakkeiden merkintään

Yhtiötiedote, Sisäpiiritieto, Helsinki 6.11.2019 klo 19.15Noin 67,4 prosenttia Nexstim Oyj:n Antioikeuksista 2019 on käytetty osakkeiden merkintäänOsakkeiden merkintäaika Nexstim Oyj:n (NXTMH:HEX, NXTMS:STO) (”Nexstim” tai ”Yhtiö”) Antioikeuksilla 2019 päättyi 4.11.2019. Antioikeuksilla merkittiin yhteensä 10 511 689 uutta osaketta, joka tuo Yhtiölle noin 1,2 miljoonan euron tuotot ennen palkkioita ja kuluja.Yhtiötiedotteen 21.10.2019 mukaisesti Antioikeudet katettiin 100 prosenttisesti merkintäsitoumuksilla ja -takauksilla, ja lisäksi päätettiin suunnatuista osakeanneista. Ehdollisena 11.11.2019 pidettävän ylimääräisen yhtiökokouksen hyväksynnälle Yhtiö järjestää enintään 15 781 416 uutta osaketta koskevan suunnatun annin, minkä odotetaan tuovan noin 1,7 miljoonan euron lisätuoton ennen palkkioita ja kuluja.Antioikeudet, joilla ei merkitty...

Continue reading

Circa 67,4 procent av Nexstim Abps Teckingsoptioner 2019 har använts för teckning av aktier

Företagsmeddelande, Insiderinformation, Helsingfors, 6 november 2019, kl. 19.15 (EET)Circa 67,4 procent av Nexstim Abps Teckingsoptioner 2019 har använts för teckning av aktierTeckningsperioden av aktier i enlighet med Nexstim Abps (NXTMH:HEX, NXTMS:STO) (“Nexstim” eller “bolaget”) Teckningsoptioner 2019 avslutades den 4 november 2019. Med Teckningsoptionerna tecknades totalt 10 511 689 nya aktier vilket kommer att tillföra cirka 1,2 miljoner euro till Bolaget före avgifter och kostnader.I enlighet med företagsmeddelandet den 21 oktober 2019 säkerställdes Teckningsoptionerna 2019 till 100 procent genom teckningsförbindelser och emissionsgarantier och därutöver fattades beslut om riktade emissioner. Villkorat av extraordinarie bolagsstämmas godkännande den 11 november 2019 kommer Bolaget att anordna en riktad emission...

Continue reading

Xebec and Asja Announce a Construction Milestone on Genoa Landfill Site

MONTREAL, Nov. 06, 2019 (GLOBE NEWSWIRE) — Xebec Adsorption Inc. (TSXV: XBC) (“Xebec”), a global provider of clean energy solutions today announced that renewable energy project developer and operator Asja Ambiente Italia SpA is in the final construction phase of its 11.2 MW landfill gas (LFG) to Renewable Natural Gas (RNG) plant in Genoa, Italy. Scheduled completion date is end of 2019. (Reference Xebec PR of March 6, 2019 – URL below).Asja is a major player in international power generation using landfill gas generated at municipal solid waste (MSW) landfill sites. With this first time ever project, Asja is transforming its Genoa landfill site installation to produce biomethane instead of electricity. Xebec’s Pressure Swing Adsorption (PSA) system was chosen for its innovative solution, delivering lower initial investment costs,...

Continue reading

Xebec e Asja annunciano il raggiungimento della fase finale del progetto di conversione dell’impianto biogas Asja di Genova

MONTREAL, Nov. 06, 2019 (GLOBE NEWSWIRE) — Xebec Adsorption Inc. (TSXV: XBC) (“Xebec”), fornitore globale di soluzioni per l’energia pulita, ha annunciato oggi che Asja Ambiente Italia SpA, azienda che progetta, costruisce e gestisce impianti di energia rinnovabile, ha raggiunto la fase finale del progetto di conversione del suo impianto di biogas da discarica di Genova (11,2 MW di capacità installata) alla produzione di gas naturale rinnovabile. Il completamento dei lavori è previsto entro la fine del 2019. (Riferimento PR Xebec del 6 marzo, 2019 – Indirizzo URL riportato in basso).Asja è tra i principali operatori internazionali nel settore della produzione di energia elettrica rinnovabile dal biogas generato nelle discariche di rifiuti solidi urbani. Con questo progetto, primo nel suo genere, Asja sta convertendo il suo...

Continue reading

Les Hôtels Baverez : Information trimestrielle 3e Trimestre 2019 – complément au 6 novembre 2019

LES HOTELS BAVEREZ S.A.2, place des Pyramides 75001 PARISCapital € 10.127.050 – Code NAF 5510 ZR.C.S. PARIS 572 158 558ISIN : FR 0007080254Mnémonique : ALLHBEURONEXT GrowthCommuniqué, Paris le 11 octobre 2019 – Complément au 6 novembre 2019COMMUNIQUE : INFORMATION TRIMESTRIELLE – 3e TRIMESTRE 2019Variation du Chiffre d’affaires au 30 septembre 2019 : + 0,77 %Le chiffre d’affaires de nos trois établissements s’élève à 24,4 millions d’euros au 30 septembre 2019, soit une faible augmentation par rapport au 30 septembre 2018.Le chiffre d’affaires global de l’Hôtel Regina perd sur ce 3e trimestre 2,36 % en cumulé au 30 septembre par rapport à 2018, principalement sur la restauration. Sur l’hébergement, son prix moyen est en augmentation de 6,0 % et son RevPar de 1,2 % pour atteindre 327,34 euros.   L’Hôtel Majestic – Spa est en repli de 10,89...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.